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amplified and calculated. The amplification of full mutation samples was successful. 
However the slippage during PCR amplification occasionally happened resulting in 
inconsistency output. So, further study on the full mutation amplification must be done. 
Remark: This study was expected to be completed by March 2009. However, it is ended 
earlier than expected due to my resignation as an academic staff in School of Medical 
Sciences, USM, effective from January 2009. 
Comprehensive Technical Report 
Real-time PCR was done to monitor the fluorescence emitted during the reaction as an 
indicator of the amplicon production during each PCR cycle in real time as opposed to 
the endpoint detection. The Real Time PCR experimental protocol was being setup in the 
Light Cycler® 1.5 Instrument (Roche Applied Science) using the Light Cycler® Software 
Version 4.05. The protocol of the amplification consisted of three programs. The 
programs are the hot start followed by the amplification and cooling procedure. 
After a series of optimization using the conventional PCR with SYBR Green, the primer 
dimer was still a major problem. To overcome this, TaqMan technology was applied. The 
reagents used for the Real-time PCR amplification was the Light Cycler® TaqMan® 
Master kit supplied by Roche. The probe was designed using the Universal Probe Library 
Software (www.universalprobelibrary.com). The probes sequence designed were added 
with new technology which is the duplex-stabilizing DNA analogue LNA (Locked 
Nucleic Acid) and was much shorter than the classic TaqMan probe, which is 25 to 35 
nucleotide probes. However, it had a high Melting temperature (Tm) yet more stable. The 
probe designed was the probe #31 (cat. no. 04687647001) with sequence 5'-TGG TOO 
AA-3'. All the primers were designed by using Primer3 Software, version 0.4.0 
(http://fokker.wi.mit.edu/primer3/input.htm). Forward primer was 5'-CTC CGT TTC 
GGT TTC ACT TC-3' and reverse primer was 5' -GTA CCT TGT AGA AAG CGC CAT 
T-3'. 
To confirm if the primers designed were correct and the sequences amplified are the 
sequence of interest located at the 5' Untranslated Region of the FMRl gene, some of the 
amplified samples were sequenced. The results obtained from the normal controlled 
samples with 30 CGG repeat showed the specificity of the primers. However, samples 
with more than 60 CGG repeats were failed to amplifY due to the high GC content. 
Like conventional PCR, high GC content leads to difficulty or even inhibit the 
amplification process. The difficulties of amplifYing the high GC content sequences are 
mostly due io the propensity of the repeats to form stable secondary structure in vitro. To 
overcome this major problem, some additives were added namely: Betaine, 7-deaza-
dGTP, DMSO and formamide. Serial optimizations of the additives concentration were 
done in order to obtain the best amplification and was found also that 7-deaza-dGTP do 
not lead to inhibition of the probe's fluorescent detection on the Real Time PCR as it 
does in Ethidium Bromide. 
Standard curve were developed from 7 DNA controls. These DNA controls which had 
been analyzed by Southern Blot were obtained from University of Amsterdam via 
collaboration between the Universities. The samples were normal repeats (30 CGG 
repeats and 45 CGG repeats), permutation (60 CGG repeats and 100-200 CGG repeats), 
full mutation with more than 200 CGG repeats, more than 300 CGG repeats and more 
than 500 CGG repeats. The CGG repeats number of the samples was calculated from the 
standard curve by using the Light Cycler Software 4.05. All the normal and permutation 
samples were successfully amplified and calculated. 
Even though the amplification of full mutation samples was successful, inconsistency of 
results occasionally happened, probably due to the slippage during PCR amplification. 
Following the hairpins structure, longer CGG repeat tracts have the possibility to form 
slipped strand DNA in the middle of amplification. So, further study of the slippage on 
the full mutation amplification and the PCR stabilization should be carried out in the near 
future. 
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Dear Editor 
It gives us great pleasure to submit a paper to the International Medical Journal. The title 
of the manuscript is: Divergence in Cytogenetic and Molecular Genetic Analysis 
Results - A Case Report of Fragile X Syndrome among Siblings. Here we report a 
pair of brothers suspected to be FXS patients with similar clinical features. We used the 
cytogenetic analysis along \\ith the molecular analysis; fragment analysis, methylation 
specific PCR and Southern blot to diagnose the Fragile X Syndrome. However, the 
cytpiCQCtjiJ result for younger brother did not show fragile site at Xq27.3 of the X 
l)hroinosome whil~ molep\111\f f\l~ult was confirmatory for FXS. Conversely, the elder 
brother showed conf11mli\Pry results for Fr11gi\l! X mutation in both cytogenetic anp 
molecular ;malysi&, Thi~ f¥Sujrs s!lo)V !In inl~r~~tinl: fiflditW \n the divergence of both the 
technique. · · · • • 
We appreci&te you for considering this manuscript for publication. 
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ABSTRACT 
Fragile X Syndrome (FXS) is the most prevalent inherited cause of mental retardation. 
The prevalence of FXS in males and females are approximately 1 in 4000 and I in 8000 
respectively. It is caused by CGG repeat instability in the FMRl gene, located on 
chromosome Xq27.3. Normal individuals have CGG repeats ranging from 5 to 53. In 
premulation carriers, the CGG repeats range from 60 to 200 and shall be more than 200 
repeats tor ti.Jil mutation patients. FXS patients have variable clinical features and 
because of that, an accurate clinical 'diagnosis is always a problem. Currently, 
Cytogenetic, PCR and Southern Blot Techniques are widely used for diagnosis of FXS. 
Here we report a pair of brothers suspected to be FXS patients with similar clinical 
features. However, the cytogenetic result for younger brother did not show fragile site at 
Xq27.3 of the X chromosome while molecular result was confirmatory for FXS. 
Conversely, the elder brother showed confirmatory results for Fragile X mutation in both 
cytogenetic and molecular analysis. We therefore conclude that cytogenetic analysis 
alone Cftnnot be dependable for the confirmatory diagnosis ofFXS. 
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Fragile X Syndrome, cytogenetic analysis, Southern Blot, FMRI gene a~d CGG repeats. 
Design: A case-control study. 
INTRODUCTION 
The Fragile X Syndrome (FXS), OMIM#300624, is the most common form of 
inherited mental retardation. The prevalence of Fragile X syndrome in males and females 
are approximately I in 4000 and I in 8000 respectively (Crawford et al., 2001). 
Approximately I in 700 females are carriers and the frequency ofpremutation in general 
population is approximately 1 in 259 females and I in 813 males (Rousseau eta/., 1995; 
.Turner et a/., 1996). However, recent I?opulation studies have indicated a much higher 
prevalence of the Fragile X Syndrome. H~.german (2008) reported that the best current 
estimate for the frequency of the FM in females is 1 in 2500 and 1 in 3600 males. 
This syndrome was the first genetic disease identified that is caused by CGG 
· repeal instability. This unstable repeat is in the FMR1 gene, located on the Xq27.3 
(Yerkerk eta!., 1991) of the X chromosome. FMR1 gene consists of 17 exons and is 
roughly 38 kb in size. Normally, the CGG repeats are stable with a range of 5 to 53 
repeats. In premutation, the CGG repeats are between 60 and 200 and the instability is 
emphasized as the number of repeats increases. When 200 or more CGG repeats are 
present, FMRI gene is usually hypermethylated, \vhich is associated with transcriptional 
silencing of the gene that is commonly referred to as the FMRI full mutation (FM) (Reiss 
et al, 1995). The FM prevents transcription of the FMRI-gene, resulting in the absence 
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